Abstract
The vaginal mucosa is a very promising route for drug administration due to its high permeability and the possibility to bypass first pass metabolism; however, current vaginal dosage forms present low retention times due to their dilution in vaginal fluids, which hampers the efficacy of many pharmacological treatments. In order to overcome these problems, this study proposes to develop a mucoadhesive in situ gelling liquid crystalline precursor system composed of 30% of oleic acid and cholesterol (7:1), 40% of ethoxylated and propoxylated cetyl alcohol, and 30% of a dispersion of 16% Poloxamer 407. The effect of the dilution with simulated vaginal fluid (SVF) on this system was evaluated by polarized light microscopy (PLM), small-angle X-ray scattering (SAXS), rheological studies, texture profile analysis (TPA), mucoadhesion study, in vitro drug release test using hypericin (HYP) as drug model, and cytotoxicity assay. PLM and SAXS confirmed the formation of an isotropic system. After the addition of three different concentrations of SVF (30, 50, and 100%), the resultant formulations presented anisotropy and characteristics of viscous lamellar phases. Rheology shows that formulations with SVF behaved as a non-Newtonian fluid with suitable shear thinning for vaginal application. TPA and mucoadhesion assays indicated the formation of long-range ordered systems as the amount of SVF increases which may assist in the fixation of the formulation on the vaginal mucosa. The formulations were able to control about 75% of the released HYP demonstrating a sustained release profile. Finally, all formulations acted as safe vaginal drug delivery systems.
Similar content being viewed by others
References
Acarturk F. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul. 2009;3(3):193–205. https://doi.org/10.2174/187221109789105658.
Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Control Release. 2005;103(2):301–13. https://doi.org/10.1016/j.jconrel.2004.11.034.
De Araújo Pereira RR, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012;38(6):643–52. https://doi.org/10.3109/03639045.2011.623355.
Okada H, Hillery AM. Vaginal drug delivery. In: Hillery AM, Swarbrick J, Lloyd AW, editors. Drug delivery and targeting for pharmacists and pharmaceutical scientists. New York and London: CRC Press; 2001. p. 274–97.
Rahamatullah S, Thakur Raghu Raj S, Martin James G, Woolfson AD, Ryan FD. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89–101. https://doi.org/10.4103/0975-7406.76478.
Carvalho FC, Campos ML, Peccinini RG, Gremião MPD. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. Eur J Pharm Biopharm. 2013;84(1):219–27. https://doi.org/10.1016/j.ejpb.2012.11.021.
Collings PJ, Hird M. Introduction to liquid crystals: chemistry and physics. CRC Press; 2017.
Calandra P, Caschera D, Turco Liveri V, Lombardo D. How self-assembly of amphiphilic molecules can generate complexity in the nanoscale. Colloids Surf A Physicochem Eng Asp. 2015;484:164–83. https://doi.org/10.1016/j.colsurfa.2015.07.058.
Huang Y, Gui S. Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion. RSC Adv. 2018;8(13):6978–87. https://doi.org/10.1039/c7ra12008g.
Malmsten M. Surfactants and polymers in drug delivery. Surfactants and polymers in drug delivery. New York: Marcel Dekker, Inc; 2003.
Fonseca-Santos B, dos Santos AM, Rodero CF, Daflon Gremião MP, Chorilli M. Design, characterization, and biological evaluation of curcumin-loaded surfactant-based systems for topical drug delivery. Int J Nanomedicine. 2016;11:4553–62. https://doi.org/10.2147/IJN.S108675.
Oyafuso MH, Carvalho FC, Takeshita TM, de Souza ALR, Araújo DR, Merino V, et al. Development and in vitro evaluation of lyotropic liquid crystals for the controlled release of dexamethasone. Polymers (Basel). 2017;9(8):1–16. https://doi.org/10.3390/polym9080330.
Salmazi R, Calixto G, Bernegossi J, Aparecido Dos M, Ramos S, Bauab TM, et al. A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasis. Int J Nanomedicine. 2015;10:4815–24. https://doi.org/10.2147/IJN.S82385.
Patel HR, Patel RP, Patel MM. Poloxamers: a pharmaceutical excipients with therapeutic behaviors. Int J Pharmtech Res. 2009;1(2):299–303. https://doi.org/10.1016/j.socscimed.2011.03.025.
Ren X, Svirskis D, Alany RG, Zargar-Shoshtari S, Wu Z. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery. Int J Pharm. 2012;431:130–7. https://doi.org/10.1016/j.ijpharm.2012.04.020.
Chen Y, Liang X, Ma P, Tao Y, Wu X, Wu X, et al. Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration. AAPS PharmSciTech. 2015;16(4):846–54. https://doi.org/10.1208/s12249-014-0277-6.
Phelps J, Bentley MVLB, Lopes LB. In situ gelling hexagonal phases for sustained release of an anti-addiction drug. Colloids Surf B: Biointerfaces. 2011;87(2):391–8. https://doi.org/10.1016/j.colsurfb.2011.05.048.
Fong WK, Hanley T, Boyd BJ. Stimuli responsive liquid crystals provide “on-demand” drug delivery in vitro and in vivo. J Control Release. 2009;135(3):218–26. https://doi.org/10.1016/j.jconrel.2009.01.009.
Boiko YA, Kravchenko IA, Novikova NS, Egorova AV, Aleksandrova DI. Effects of liquid crystal systems based on cholesterol esters on skin permeability. Pharm Chem J. 2013;47(7):393–6. https://doi.org/10.1007/s11094-013-0966-6.
Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15:1032–40. https://doi.org/10.1016/j.drudis.2010.09.006.
Crane JM, Tamm LK. Role of cholesterol in the formation and nature of lipid rafts in planar and spherical model membranes. Biophys J. 2004;86(5):2965–79. https://doi.org/10.1016/S0006-3495(04)74347-7.
Toffoli D, Courrol L, Tarelho LV. Estudo do complexo Hipericina-Európio para uso em diagnóstico. Boletim Técnico da Faculdade de Tecnologia de São Paulo; 2006.
Sytar O, Švedienė J, Ložienė K, Paškevičius A, Kosyan A, Taran N. Antifungal properties of hypericin , hypericin tetrasulphonic acid and fagopyrin on pathogenic fungi and spoilage yeasts. Pharm Biol. 2016;54(12):3121–5. https://doi.org/10.1080/13880209.2016.1211716.
Shih C, Wu C, Wu W, Hsiao Y, Ko J. Hypericin inhibits hepatitis C virus replication via deacetylation and down-regulation of heme oxygenase-1. Phytomedicine. 2017;46:193–8. https://doi.org/10.1016/j.phymed.2017.08.009.
Dellafiora L, Galaverna G, Cruciani G, Asta CD, Bruni R. On the mechanism of action of anti-inflammatory activity of hypericin : an in silico study pointing to the relevance of Janus kinases inhibition. Molecules. 2018;23(12):3058. https://doi.org/10.3390/molecules23123058.
Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2017;473(4):347–64. https://doi.org/10.1042/BJ20150942.
Ghazanfarpour M, Abdolahian S, Khadivzadeh T, Kaviani M. Hypericum perforutum and vitamin B6 as a treatment for premenstrual syndrome. 2017;12(2):1–6. https://doi.org/10.5812/jjnpp.34093.
Penjweini R, Deville S, Ethirajan A, Ameloot M. Investigating the intracellular dynamics of correlation spectroscopy. In: Hamblin MR, Avci P, Prow T, editors. Nanoscience in dermatology. London: Academic Press; 2016. p. 275–86.
Kamal A, Ahmad FJ, Ahmad S, Saleem K. A validated HPLC method for the quantification of hypericin in hypericum perforatum. Asian J Chem. 2012;24(10):4689–92.
Nunes KM, Teixeira CCC, Kaminski RCK, Couto O, Pulcinelli SH, Freitas O, et al. The monoglyceride content affects the self-assembly behavior , rheological properties , syringeability , and mucoadhesion of in situ e gelling liquid crystalline phase. 2016:1–10. https://doi.org/10.1016/j.xphs.2016.05.005.
Wu Z, Alany RG, Tawfeek N, Falconer J, Zhang W, Hassan IM, et al. A study of microemulsions as prolonged-release injectables through in-situ phase transition. J Control Release. 2014;174:188–94. https://doi.org/10.1016/j.jconrel.2013.11.022.
Calixto GMF, Victorelli FD, Dovigo LN, Chorilli M. Polyethyleneimine and chitosan polymer-based mucoadhesive liquid crystalline systems intended for buccal drug delivery. AAPS PharmSciTech. 2017;19(2):820–36. https://doi.org/10.1208/s12249-017-0890-2.
Shrestha LK, Sato T, Shrestha RG, Hill J, Ariga K, Aramaki K. Structure and rheology of reverse micelles in dipentaerythrityl tri-(12-hydroxystearate)/oil systems. Phys Chem Chem Phys. 2011;13(11):4911–8. https://doi.org/10.1039/C0CP02024A.
Mezzenga R, Meyer C, Servais C, Romoscanu AI, Sagalowicz L, Hayward RC. Shear rheology of lyotropic liquid crystals : a case study. 2005;21(8):3322–33. https://doi.org/10.1021/la046964b.
Cordobés BF, Franco JM, Gallegos C. Rheology of the lamellar liquid-crystalline phase in polyethoxylated alcohol / water / heptane systems. Grasas Aceites. 2005;56:96–105.
Zhao J, Wang ZN, Wei XL, Liu F, Zhou W, Tang XL, et al. Phase behaviour and rheological properties of the lamellar liquid crystals formed in dodecyl polyoxyethylene polyoxypropylene ether/water system. NISCAIR. 2011;50(5):641–9.
Chorilli M, Prestes PS, Rigon RB, Leonardi GR, Chiavacci LA, Sarmento VHV, et al. Structural characterization and in vivo evaluation of retinyl palmitate in non-ionic lamellar liquid crystalline system. Colloids Surf B: Biointerfaces. 2011;85(2):182–8. https://doi.org/10.1016/j.colsurfb.2011.02.027.
Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71(3):505–18. https://doi.org/10.1016/j.ejpb.2008.09.028.
Yakubov GE, Singleton S, Williamson AM. Methods for assessing mucoadhesion: the experience of an integrative approach. In: Khutoryanskiy VV, editor. Mucoadhesive materials and drug delivery systems. United Kingdom: Wiley; 2014. p. 197–232.
Ruela ALM, Carvalho FC, Pereira GR. Exploring the phase behavior of monoolein/oleic acid/water systems for enhanced donezepil administration for Alzheimer disease treatment. J Pharm Sci. 2016;105(1):71–7. https://doi.org/10.1016/j.xphs.2015.10.016.
Rençber S, Karavana SY, Yilmaz FF, Eraç B, Nenni M, Gurer-Orhan H, et al. Formulation and evaluation of fluconazole loaded oral strips for local treatment of oral candidiasis. J Drug Deliv Sci Technol. 2019;49:615–21. https://doi.org/10.1016/j.jddst.2018.12.035.
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33. https://doi.org/10.1016/S0928-0987(01)00095-1.
Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309(1–2):44–50. https://doi.org/10.1016/j.ijpharm.2005.10.044.
Pan J, Tristram-Nagle S, Nagle JF. Effect of cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation. Phys Rev E Stat Nonlinear Soft Matter Phys. 2009;80(2):021931. https://doi.org/10.1103/PhysRevE.80.021931.
Joniova J, Rebič M, Strejčková A, Huntosova V, Staničová J, Jancura D, et al. Formation of large hypericin aggregates in giant unilamellar vesicles—experiments and modeling. Biophys J. 2017;112(5):966–75. https://doi.org/10.1016/j.bpj.2017.01.019.
Bánó G, Staničová J, Jancura D, Marek J, Bánó M, Uličný J, et al. On the diffusion of hypericin in dimethylsulfoxide/water mixtures-the effect of aggregation. J Phys Chem B. 2011;115(10):2417–23. https://doi.org/10.1021/jp109661c.
Ho YF, Wu MH, Cheng BH, Chen YW, Shih MC. Lipid-mediated preferential localization of hypericin in lipid membranes. Biochim Biophys Acta Biomembr. 2009;1788(6):1287–95. https://doi.org/10.1016/j.bbamem.2009.01.017.
Eriksson ESE, Eriksson LA. The influence of cholesterol on the properties and permeability of hypericin derivatives in lipid membranes. J Chem Theory Comput. 2011;7(3):560–74. https://doi.org/10.1021/ct100528u.
Yu AX, Mu Y, Xu M, Xia G, Wang J, Liu Y, et al. Preparation and characterization of mucosal adhesive and two-step drug releasing cetirizine-chitosan nanoparticle. Carbohydr Polym. 2017;173:600–9. https://doi.org/10.1016/j.carbpol.2017.05.067.
Fonseca Y, Pitol DL. Evaluation of protective effect of a water-in-oil microemulsion incorporating quercetin against UVB-induced damage in hairless mice skin. J Pharm Pharm Sci. 2010;13(2):274–85. https://doi.org/10.18433/J3830G.
Shen H, Crowston JG, Huber F, Saubern S, Mclean KM, Hartley PG. The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions. Biomaterials. 2010;31(36):9473–81. https://doi.org/10.1016/j.biomaterials.2010.08.030.
Hosmer J, Reed R, Bentley MVLB, Nornoo A, Lopes LB. Microemulsions containing medium-chain glycerides as transdermal delivery systems for hydrophilic and hydrophobic drugs. AAPS PharmSciTech. 2009;10(2):589–96. https://doi.org/10.1208/s12249-009-9251-0.
Gosenca M, Bešter-Rogac M, Gašperlin M. Lecithin based lamellar liquid crystals as a physiologically acceptable dermal delivery system for ascorbyl palmitate. Eur J Pharm Sci. 2013;50:114–22. https://doi.org/10.1016/j.ejps.2013.04.029.
Jendželovská Z, Jendželovský R, Kuchárová B, Fedoročko P. Hypericin in the light and in the dark: two sides of the same coin. Front Plant Sci. 2016;7:1–20. https://doi.org/10.3389/fpls.2016.00560.
Acknowledgments
We thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) that was funded this research (grant #2017/10016-2), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Programa de Apoio ao Desenvolvimento Científico (PADC).This study was also financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Araújo, P.R., Calixto, G.M.F., da Silva, I.C. et al. Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs. AAPS PharmSciTech 20, 225 (2019). https://doi.org/10.1208/s12249-019-1439-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-019-1439-3